Treatment of supraventricular tachycardias in the new millennium--drugs or radiofrequency catheter ablation?
Supraventricular tachycardias are a cause of significant morbidity in children. Newer anti-arrhythmic drugs and the invention of radiofrequency catheter ablation have revolutionised anti-arrhythmic therapy in children.


CONCLUSIONS
With the availability of these very effective therapeutic options, an improved knowledge of these methods and their indications is required.
Bauersfeld
U
U
Department of Paediatric Cardiology, University Children's Hospital, Zurich, Switzerland. bauersfe@kispi.unizh.ch
Pfammatter
J P
JP
Jaeggi
E
E
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D002648:Child; D006801:Humans; D013617:Tachycardia, Supraventricular / Q000503:physiopathology / Q000628:therapy*
D000889:Anti-Arrhythmia Agents